期刊
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
卷 98, 期 -, 页码 237-240出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2020.06.089
关键词
RT-PCR; Serological; SARS-CoV-2; Laboratory; Test kits; Africa; Assay
资金
- German Research Foundation through the Neurocognition and Action-Biomechanics Research Group, Bielefeld University, Germany
The dramatic increase in suspected COVID-19 cases in Africa has placed an enormous burden on public and private clinical facilities. To date, the most commonly used method for identifying and confirming the virus is the laboratory-based reverse transcription-polymerase chain reaction (RT-PCR) test. Unfortunately, testing capacities have been limited in many parts of Africa because of inadequate test kits, which have restricted scaling up beyond the few public health laboratories at designated locations. In this mini-review, we present Africa's preparedness and readiness for testing, why testing is crucial, the need to immediately strengthen existing facilities, and what it involves as part of combined approaches for managing the COVID-19 crisis. The review highlights the urgent need for speedy expansion and distribution of several laboratory testing platforms, including real-time PCR and serological assays to both public health facilities and fully accredited private clinical laboratories. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据